Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • Saudi Medical Journal

User menu

  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurosciences Journal
  • Other Publications
    • Saudi Medical Journal
  • My alerts
  • Log in
  • Log out
Neurosciences Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
Research ArticleOriginal Article
Open Access

Type and etiology of pediatric epilepsy in Jordan

a multi-center study

Abdelkarim A. Al-Qudah, Abla Albsoul-Younes, Amira T. Masri, Samah K. AbuRahmah, Ibrahim A. Alabadi, Omar A. Nafi, Lubna F. Gharaibeh, Amer A. Murtaja, Lina H. Al-Sakran, Haya A. Arabiat and Abdallah A. Al-Shorman
Neurosciences Journal October 2017, 22 (4) 267-273; DOI: https://doi.org/10.17712/nsj.2017.4.20170164
Abdelkarim A. Al-Qudah
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD, ABCN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Abla Albsoul-Younes
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amira T. Masri
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samah K. AbuRahmah
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ibrahim A. Alabadi
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar A. Nafi
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lubna F. Gharaibeh
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amer A. Murtaja
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
Bsc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina H. Al-Sakran
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haya A. Arabiat
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdallah A. Al-Shorman
From the Department of Pediatrics (Al-Qudah, Masri), Faculty of Medicine, Department of Bio pharmaceutics and Clinical Pharmacy (Albsoul-Younes, Alabadi, Gharaibeh, Murtaja, Al-Sakran), Faculty of Pharmacy, Hamdi Mango Centre for Scientific Research (Albsoul-Younes), University of Jordan, Amman, from the Department of Pediatrics (AbuRahmah), Faculty of Medicine, Jordan University of Science and Technology, Irbid, from the Faculty of Medicine (Nafi), University of Mutah, Karak, Jordan, from Salt Hospital (Arabiat), Salt, and from Prince Rahma Hospital (Al-Shorman), Irbid, Ministry of Health, Jordan
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

Abstract

Objective: To study types and etiologies of epilepsy in Jordanian pediatric epileptic patients maintained on antiepileptic drugs using customized classification scheme of International League Against Epilepsy (ILAE) (2010) report.

Methods: This is a cross-sectional, multi-centre study on paediatric epileptic patients on antiepileptic drugs, who were managed in the pediatric neurology clinics at 6 teaching public hospitals in Jordan.

Results: Out Of the 663 patients included in the study, (90.2%) had one seizure type, (53%) of this type were focal seizures followed by generalized seizures (41.5%) and spasms (5.5%). Distinctive constellations were found in 11/663 (1.7%) patients. Benign epilepsies with centrotemporal spikes were the most common electro clinical syndromes 60/221 (27.1%). Epilepsies attributed to structural-metabolic causes were documented in 278/663 (41.9%) patients, unknown causes 268/663(40.4%) and genetic causes in 117/663(17.7%). Most common causes of structural-metabolic group were due to perinatal insults (32%) and most common causes of the genetic group were the presumed genetic electro clinical syndromes (93.1%).

Conclusion: Our study is on pediatric epilepsy, using customized classification scheme from the ILAE 2010 report which showed interesting results about type and etiology of epileptic seizures from developing country with potential impact on the international level.

Classification plays an important role in management of epileptic patients, education and epilepsy research. Since the first classification in 1960, tremendous developments have happened in the fields of neuroimaging, neurophysiology, genomic technology and molecular biology, which paved the road for the report of International League Against Epilepsy (ILAE) commission on classification and terminology of epileptic seizures (2005-2009).1 The report has attracted a lot of debate regarding its value compared to the ones previously used and current and future research will test the usefulness and validity of its contents.2-7 Operational classification of seizure types by the ILAE: Position Paper of the ILAE Commission for Classification and Terminology has been recently published.2 Few clinical studies have shown some usefulness of the revised classification of the ILAE report 2010.8-11 The aim of our study was to determine the classification of mode of onset of seizures, types of epilepsies and their etiology, using the proposed Report of the ILAE Commission on Classification and Terminology of epileptic seizures (2010).

Methods

This is a cross-sectional, multi-center study, on Jordanian pediatric epileptic patients maintained on antiepileptic drugs, using the proposed report of the ILAE Commission on Classification and Terminology of epileptic seizures (2010).

Study design

The study was a cross-sectional, multi-center study, where all patients diagnosed as epileptic and maintained on antiepileptic drugs were included consecutively in the study during the study period from September 2013 to January 2016. Age at onset of seizures was from birth to 18 years. The study was carried out in 6 public teaching hospitals. Two of the hospitals were university hospitals, 4 were ministry of health (MOH) hospitals, 3 of the MOH hospitals were affiliated to the university hospitals. Two hospitals were located in the north of Jordan, 3 in the middle and one in the south. Great collaboration is present among these hospitals in different services including clinical, educational and investigations services. Also, when necessary, some unavailable genetic and metabolic investigations were carried out in other medical centers in Jordan or abroad. Clinical data were documented in the study forms directly from the patients, their families and from their clinical records during the study period by the pediatric neurologist working in each hospital.

Classification was carried out by one pediatric neurologist. However; all data in the study forms were reviewed by the first author. Whenever there were questions concerning the classification or etiology or both, the cases were discussed with the assigned pediatric neurologist till the final decision was reached. In one of the MOH hospitals, all patients included in the study were evaluated directly by the first author and the assigned pediatric neurologist (co-author) in that hospital. In another MOH hospital, the first author reviewed all patients’ medical records with the assigned pediatric neurologist (co-author) in that hospital.

Inclusion and exclusion criteria

All patients aged 2 months-18 years who had a final diagnosis of epilepsy and maintained on antiepileptic drugs were included in the study.12 All patients with febrile seizures, acute symptomatic seizures and isolated neonatal seizures were excluded as carried out by Syvertsen et al.13

Ethical approval

The ethical approval for the study conduction was obtained from IRB committee in the hospitals where the study was carried out. Guardian, of eligible patient was asked for permission of enrolment of his child. After obtaining consent from the child’s legal guardians, a case report form was used to collect pertinent information.

Statistics

The data were analyzed using the IBM® SPSS® Statistics for Windows version 21.0 (IBMCorp, Armonk, NY, USA). Categorical data were summarized using frequencies and percentages n (%) and continuous data were described using the mean and standard deviation (mean±SD). Chi square was used to test for statistically significant difference in categorical data. P-values less than 0.05 were considered statistically significant.

Data and classifications

Collected data included the following: age at first presentation, age at onset of seizures, gender, medical history, developmental history, family history, seizure semiology, physical and neurological signs, response to anticonvulsive treatment, electroencephalography recordings, neuroimaging studies, genetic testing, metabolic and any other relevant investigations.

Epileptic seizures, electro clinical syndromes and their etiologies were classified according to the scheme proposed by the ILAE in 2010.1 Mode of onset of seizure was considered generalized if the patient had generalized-onset seizures and generalized epileptic form discharges on EEG. Patients were classified as focal if they had focal-onset seizure. Additionally, patients with generalized tonic-clonic seizures and focal finding on neurological examination, neuroimaging or EEG, were considered to have focal seizures. Epileptic patients who had more than one seizure type were considered to have mixed epileptic seizures (Table 1). Patients who presented with spasms and developed later other seizure types were considered to have spasms. Patients who presented with focal or generalized seizure and later developed spasms were considered to have both spasms and other seizure types and documented in Table 1 as mixed epileptic seizures. Patients were classified to have genetic etiology if they had strong genetic contribution such as childhood absence epilepsy or juvenile myoclonic epilepsy or if they had chromosomal disorders or genetic mutation for their epilepsy. Neurocutaneous syndromes which give rise to structural brain abnormalities and distinctive constellations were classified as having structural etiology. Moreover, focal seizures with unknown etiology were further classified according to the lobe they originate from or undetermined if not possible to refer to specific lobe which may help in clarifying this group further. Epileptic seizures were considered drug-resistant when occurred at least monthly for more than 6 months and after adequate use of 2 antiepileptic drugs.11 At least, one EEG was carried out on every patient; neuroimaging was carried out on 91.7% of all cases and brain MRIs were carried out on 75% of all cases (Table 1).

View this table:
  • View inline
  • View popup
Table 1

Seizure types, their characteristics and main investigations of 663 Jordanian pediatric epileptic patients.

Results

Results showed mainly mode of onset, type and etiology of epileptic seizures in Jordanian epileptic patients. A group of 663 patients were included in the study and another group of 61 patients were excluded from the study because of inadequate information. Most patients (96.5%) were evaluated in the pediatric neurology clinics after age of one year. Also, 27.1% of all epileptic patients had their first seizure before age of one year. Slight and significant increase in male to female ratio was noted (p<0.001) (Table 2).

View this table:
  • View inline
  • View popup
Table 2

Demographic data of 663 Jordanian pediatric epileptic patients.

One seizure type was reported in 598 (90.2%) of all epileptic patients and the focal epileptic seizures of this group were significantly the most common 317 (53%) (p<0.001), followed by generalized 248 (41.5%) and epileptic spasms 33 (5.5%) (Table 1). Focal seizures with impairment of consciousness or awareness (F with ICA) were significantly the most common focal epileptic seizure 178/317 (56.2%) and tonic clonic seizures were the most common generalized epileptic seizures 139/248 (56%) (p<0.001) (Table 1). Infact, focal seizures are more common to present in the first year (n=73) than generalized seizures (n=58) (p<0.001) (Table 3). One third of all epileptic seizures were due to electro clinical syndromes and 60/221 (27.1%) of electro clinical syndromes were due to benign epilepsy with centro-temporal spikes (BECTS) followed by absence epilepsy 41/221 (18.6%) (Table 4).

View this table:
  • View inline
  • View popup
Table 3

Age at onset of epileptic seizures, their types and aetiology.

View this table:
  • View inline
  • View popup
Table 4

Electro clinical syndromes of 221 Jordanian pediatric epileptic patients.

The etiology of epilepsies are shown in Table 5. Apparently, structural-metabolic causes were the most common 278 (41.9%), followed by unknown causes in 268 (40.4%) and genetic causes in 117 (17.7%) patients. Genetic group causes consisted of 2 subgroups. The first included 109 electro clinical syndromes and considered to have presumed genetic causes and the second subgroup included 8 patients who had genetic disorders in which epileptic seizures do not constitute a core symptom but are rather an association to the primary phenotype. That second subgroup included the following disorders: 2 fragile x syndromes, one Prader-Willi Syndrome, one Angleman syndrome, one 46, xx-14, RING14 abnormality, one Rett syndrome, one Bloom syndrome and one Rubenstein-Taybi syndrome (Table 5).

View this table:
  • View inline
  • View popup
Table 5

Etiology of epilepsies of 663 patients.

Electro clinical syndromes group (n=221) was due to presumed genetic causes in 109 (49.3%) patients, followed by unknown causes 82 (37.1%) and structural-metabolic causes 30 (13.6%) (Table 4).

Of the structural–metabolic group, 89/278(32%) were due to perinatal disorders and were the most common causes of this group, followed by malformation of cortical development 26/278 (9.3%) (Table 5). The unknown causes group in our study consisted of electro clinical syndromes 82/268 (30.6%) and other types of epilepsies 186/268 (69.4%) (Table 5). Structural-metabolic causes significantly predominated in the first year 109/180 (60.5%) and unknown etiology predominated after the first year 217/483 (44.9%) (Table 3) (p<0.001). Moreover, Table 3 showed that age at onset of epileptic seizures was in the first 12 years in 658/663 (99.2%) and was in the first 6 years in 553/663 (83.4%) patients.

Discussion

There is little published research on type and etiology of epilepsy in pediatrics using the ILAE report 2010. Our study is about classification and etiology of epilepsies using the ILAE report 2010 and among few studies in the international level.3,8-11,13 In fact, 4 of these studies included pediatric epileptic patient3,8-9,11 and 2 of them were hospital-based, one of them used the 2010 ILAE report similar to our study11 and the other one used the previous classifications for comparison with the 2010 ILAE report.3 Our study is also, unique in being multi-center.

Age at onset of seizures in the first year of life in our study was 27.1%, which is less than that of Khoo’s study (42.1%),11 but similar to other studies.3,8,14 Age at onset of epilepsies in the age group >1-12 years, was documented in 72.9% of patients in our cohort, which is comparable to that reported by other studies.8,11

Most common type of epileptic seizures presenting with one seizure type was focal in our study (53%) (Table 1). This finding is comparable to other studies which revealed that (53.3-69%) of new onset epilepsy was focal.11,14-15 Also, the most common type of focal seizures was (F with ICA) (56.2%) and approximately quarter of the focal seizures evolved to bilateral convulsive seizures (BCS). Although, the ambiguity using complex partial seizures in the old classification is replaced by more meaningful terminology in the new classification of the 2010 ILAE report, the description of types of focal seizures, looks lengthy like (F with ICA evolving to BCS) and probably needs modification.3,6 Forty patients (6%) in our study had epileptic spasms and 33 of them were due to West syndrome. Other studies reported epileptic spasms in (3-8%) of patients.8,11,16

Electro clinical syndromes were identified in 33.3% of our epileptic patients when compared to (14-28%) in other studies.8,11,13 The BECTS accounted for 27.1% of all electro clinical syndrome in our study which is in contrary to what was reported by Syvertsen et al13 who found that absence epilepsy (both childhood and juvenile) was the most common electro clinical syndromes (36.1%) and BECTS accounted for only (18%).13 The high incidence of BECTS in our study may be also, attributed partially to over treatment of such entity in Jordan. Distinctive constellations were documented in (1.7%) in our study which is comparable to that reported by other studies.8,11

Structural-metabolic causes were the most common causes of epilepsies in our study (41.9%) which are comparable to other studies.3,8,11,13 Most patients of this group (87.4%) had their seizure onset in the first 6 years and 39.2% of the group had their seizures onset in the first year of life, which is slightly higher than that reported by Weirell et al8 (Table 3). Perinatal disorders were the most common causes of this group (32%), which is slightly lower than study from Saudi Arabia (40%) that was carried out long time ago in 1990,17 and much higher than the Norwegian study (14%).13 This high rate of perinatal causes of epilepsies indicates that developing countries like Jordan have to work hard on improving the perinatal care and the associated morbidity.

Unknown causes represented 40.4% of all patients in our study. Other studies reported (23.5-50%) of their patients to have unknown causes.8,11 That means there is much to be learned about epilepsy in children, because of high percentage of unknown causes hoping that the advances in genetic technology and molecular biology will decrease the size of this group.

Although genetic causes represented (17.7%) of all cases in our study (Table 5), some of the electro clinical syndromes included in this group of causes have little confirmed evidence of genetic basis,18 in the contrary, some metabolic disorders like phenyl ketoneurea and structural disorders like tuberous sclerosis are considered part of structural-metabolic group, although they have some genetic basis. Moreover, electro clinical syndromes classified under unknown like Ohtahara syndrome and BECTS have possible genetic contribution.19-20

Drug-resistant epilepsies were documented in 24.3% of our patients which is more than reported by Rasmos-Lizana et al (17%)21 and less than khoo study (45%)11 and Boonluksiri et al(42%).22

Despite the clarity of terminology in ILAE 2010 report, when compared to old classification, it was difficult for the project team to use the lengthy terminology for focal seizures. Obviously, the 2010 classification gave better insight to the understanding of the type of epileptic seizures, etiology of epilepsies, particularly, genetic causes which are significantly growing field, where greater integration of genetics into clinical decision making is an emerging trend23 and distinctive constellations as possible surgical candidates.24

Limitation of the study

Potential weakness of our study was that the classification and etiology were performed mainly by one pediatric neurologist, though the whole data were reviewed by the first author. As mentioned in the study design, whenever necessary, Patients and/or their medical records were reviewed again, by the first author. Also, we have not been able to find many hospital-based studies using the revised terminology proposed by the ILAE in 2010 to compare their results with ours. However; we considered the new categories of genetic, structural-metabolic and unknown in 2010 report correspond to the previous idiopathic, symptomatic, and cryptogenic terminology.13 Moreover, the nature of our hospital-based study cannot give optimal epidemiological data. Obviously, in resource–limited countries like Jordan, some modification in classification of ILAE 2010 report is required due to limitation in availability of advanced genetic investigations.10-11

In conclusion, our study as the first study from the Middle East using the ILAE 2010 report and unique in being hospital-based and multicenter on the international level, demonstrated that focal epilepsies were the most common type of pediatric epilepsy, the structural-metabolic causes were the most common causes of epilepsy, the genetic causes were mainly due to presumed genetic causes. Larger population-based studies using the current and future classifications and terminology of the ILAE for epileptic seizures may give more optimal epidemiological data about types and etiologies of epilepsies.

Footnotes

  • Disclosure

    This work was funded by the Scientific Research Support Funds, Ministry of Higher Education and Scientific Research, Amman, Jordan, (Grant No. MPH/1/02/2012). The authors declare no conflicting interests, support or funding from any drug company.

  • Received March 14, 2017.
  • Accepted August 1, 2017.
  • Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

References

  1. ↵
    1. Berg AT,
    2. Berkovic SF,
    3. Brodie MJ,
    4. Buchhalter J,
    5. Cross JH,
    6. van Emde Boas W,
    7. et al.
    (2010) Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology 2005–2009. Epilepsia 51, 676–685.
  2. ↵
    1. Fisher RS,
    2. Cross JH,
    3. French JA,
    4. Higurashi N,
    5. Hirsch E,
    6. Jansen FE,
    7. et al.
    (2017) Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58, 522–530.
  3. ↵
    1. van Campen JS,
    2. Jansen FE,
    3. Brouwer OF,
    4. Nicolai J,
    5. Braun KP
    (2013) Interobserver agreement of the old and the newly proposed ILAE epilepsy classification in children. Epilepsia 54, 726–732.
    1. Korff CM,
    2. Scheffer IE
    (2013) Epilepsy classification: a cycle of evolution and revolution. Curr Opin Neurol 26, 163–167.
    1. Berg AT,
    2. Cross JH
    (2012) Classification of epilepsies and seizures: historical Perspective and future directions. Handb Clin Neurol 107, 99–111.
  4. ↵
    1. Panayiotopoulos CP
    (2012) The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 53, 399–404.
  5. ↵
    1. Luders HO,
    2. Amina S,
    3. Baumgartner C,
    4. Benbadis S,
    5. Bermeo-Ovalle A,
    6. Devereaux M,
    7. et al.
    (2012) Modern technology calls for a modern approach to classification of epileptic seizures and the epilepsies. Epilepsia 53, 405–411.
  6. ↵
    1. Wirrell E,
    2. Grossardt B,
    3. Wong-Kisiel L,
    4. >Nickels KC
    (2011) Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: A population-based study. Epilepsy Res 95, 110–118.
  7. ↵
    1. Mühlebner A,
    2. Gröppel G,
    3. Dressler A,
    4. Reiter-Fink E,
    5. Kasprian G,
    6. Prayer D,
    7. et al.
    (2014) Epilepsy surgery in children and adolescents with malformations of cortical development--outcome and impact of the new ILAE classification on focal cortical dysplasia. Epilepsy Res 108, 1652–1661.
  8. ↵
    1. Uttam AK,
    2. Joshi R,
    3. Dwivedi R,
    4. Prasad K,
    5. Padma Mv,
    6. Bahatia R,
    7. et al.
    (2013) Applicability of the new ILAE classification for epilepsies (2010) in persons with epilepsy at a tertiary care centre in India. Epilepsia 54, 751–756.
  9. ↵
    1. Khoo T
    (2013) Classification of Childhood Epilepsies in a Tertiary Pediatric Neurology Clinic Using a Customized Classification Scheme from the International League against Epilepsy 2010 Report. Child Neurol 28, 56–59.
  10. ↵
    1. Fisher RS,
    2. van Emde Boas W,
    3. Blume W,
    4. Elger C,
    5. Genton P,
    6. Lee P,
    7. et al.
    (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46, 470–472.
  11. ↵
    1. Syvertsen M,
    2. Nakken KO,
    3. Edland A,
    4. Hansen G,
    5. Hellum MK,
    6. Koht J
    (2015) Prevalence and etiology of epilepsy in a Norwegian county-A population based study. Epilepsia 56, 699–706.
  12. ↵
    1. Ünver O,
    2. Keskin PS,
    3. Uysal S,
    4. Ünver A
    (2015) The Epidemiology of Epilepsy in Children: A Report From a Turkish Paediatric Neurology Clinic. J Child Neurol 30, 698–702.
  13. ↵
    1. Hirfanoglu T,
    2. Serdaroglu A,
    3. Capraz I,
    4. Bilir E,
    5. Arhan EP,
    6. Aydin K
    (2017) Comparison of ILAE 2010 and semiological seizure classification in children with epilepsy. Epilepsy Res 129, 41–50.
  14. ↵
    1. Ahmed S,
    2. Alam ST,
    3. Rahman MM,
    4. Akhter S
    (2016) Clinical Profile of Early Childhood Epilepsy: A Cross Sectional Study in a Tertiary Care Hospital. Mymensingh Med J 25, 96–101.
  15. ↵
    1. Al-Rajeh S,
    2. Abomelha A,
    3. Awada A,
    4. Bademosi O,
    5. Ismail H
    (1990) Epilepsy and other convulsive disorders in Saudi Arabia: a prospective study of 1,000 consecutive cases. Acta Neurol Scand 82, 341–345.
  16. ↵
    1. Gürsoy S
    (2016) Diagnostic approach to genetic Causes of early-onset epileptic encephalopathy. J Child Neurol 31, 523–532.
  17. ↵
    1. Kodera H,
    2. Ohba C,
    3. Kato M,
    4. Maeda T,
    5. Araki K,
    6. Tajima D,
    7. et al.
    (2016) De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia 57, 566–573.
  18. ↵
    1. Che XQ,
    2. Sun ZF,
    3. Mao X,
    4. Xia K,
    5. Yan XX,
    6. Jiang H,
    7. et al.
    (2017) Mutation screening of the PRRT2 gene for benign epilepsy with centrotemporal spikes in Chinese mainland population. Int J Neurosci 127, 10–13.
  19. ↵
    1. Ramos-Lizana J,
    2. Rodriguez-Lucenilla MI,
    3. Aguilera-López P,
    4. Aguirre-Rodríguez J,
    5. Cassinello-García E
    (2012) A study of drug-resistant childhood epilepsy testing the new ILAE criteria. Seizure 21, 266–272.
  20. ↵
    1. Boonluksiri P,
    2. Visuthibhan A,
    3. Katanyuwong K
    (2015) Clinical Prediction Rule of Drug Resistant Epilepsy in Children. J Epilepsy Res 5, 84–88.
  21. ↵
    1. Helbig I,
    2. Heinzen EL,
    3. Mefford HC,
    4. ILAE Genetics Commission
    (2016) ILAE Genetics Commission. Primer Part 1-The building blocks of epilepsy genetics. Epilepsia 57, 861–868.
  22. ↵
    1. Tugcu B,
    2. Gungor A,
    3. Akpinar A,
    4. Kinay D,
    5. Kuscu DY,
    6. Gül G,
    7. et al.
    (2016) Outcome of surgical treatment of hippocampal sclerosis from relatively new epilepsy surgery center. J Neurosurg Sci 60, 159–168.
PreviousNext
Back to top

In this issue

Neurosciences Journal: 22 (4)
Neurosciences Journal
Vol. 22, Issue 4
1 Oct 2017
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Neurosciences Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Type and etiology of pediatric epilepsy in Jordan
(Your Name) has sent you a message from Neurosciences Journal
(Your Name) thought you would like to see the Neurosciences Journal web site.
Citation Tools
Type and etiology of pediatric epilepsy in Jordan
Abdelkarim A. Al-Qudah, Abla Albsoul-Younes, Amira T. Masri, Samah K. AbuRahmah, Ibrahim A. Alabadi, Omar A. Nafi, Lubna F. Gharaibeh, Amer A. Murtaja, Lina H. Al-Sakran, Haya A. Arabiat, Abdallah A. Al-Shorman
Neurosciences Journal Oct 2017, 22 (4) 267-273; DOI: 10.17712/nsj.2017.4.20170164

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Type and etiology of pediatric epilepsy in Jordan
Abdelkarim A. Al-Qudah, Abla Albsoul-Younes, Amira T. Masri, Samah K. AbuRahmah, Ibrahim A. Alabadi, Omar A. Nafi, Lubna F. Gharaibeh, Amer A. Murtaja, Lina H. Al-Sakran, Haya A. Arabiat, Abdallah A. Al-Shorman
Neurosciences Journal Oct 2017, 22 (4) 267-273; DOI: 10.17712/nsj.2017.4.20170164
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Do people with multiple sclerosis in Saudi Arabia want to know their prognosis? A cross-sectional nationwide study
  • Risk factors, clinical characteristics, and outcomes of perinatal stroke in a Tertiary University Hospital
  • The association between cigarette smoking and sleep deprivation among adolescents in Gulf Cooperation Council countries: analysis of national surveys
Show more Original Article

Similar Articles

Navigate

  • home

More Information

  • Help

Additional journals

  • All Topics

Other Services

  • About

© 2025 Neurosciences Journal Neurosciences is copyright under the Berne Convention and the International Copyright Convention. All rights reserved. Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3183. Print ISSN 1319-6138.

Powered by HighWire